Coeptis Therapeutics Stock Buy Hold or Sell Recommendation
| COEP Stock | USD 11.10 0.09 0.82% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Coeptis Therapeutics is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell Coeptis Therapeutics within the specified time frame.
Check out Coeptis Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Coeptis Stock, please use our How to Invest in Coeptis Therapeutics guide. Note, we conduct extensive research on individual companies such as Coeptis and provide practical buy, sell, or hold advice based on investors' constraints. Coeptis Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Coeptis |
Execute Coeptis Therapeutics Buy or Sell Advice
The Coeptis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Coeptis Therapeutics. Macroaxis does not own or have any residual interests in Coeptis Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Coeptis Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Good | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Excited | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Coeptis Therapeutics Trading Alerts and Improvement Suggestions
| Coeptis Therapeutics is way too risky over 90 days horizon | |
| Coeptis Therapeutics appears to be risky and price may revert if volatility continues | |
| Coeptis Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Coeptis Therapeutics currently holds 1.22 M in liabilities with Debt to Equity (D/E) ratio of 1.89, which is about average as compared to similar companies. Coeptis Therapeutics has a current ratio of 0.55, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Coeptis Therapeutics' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (21.27 M) with profit before overhead, payroll, taxes, and interest of 75 K. | |
| Coeptis Therapeutics currently holds about 2.38 M in cash with (7.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. | |
| Coeptis Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Roughly 19.0% of Coeptis Therapeutics shares are held by company insiders | |
| Latest headline from gurufocus.com: Coeptis Therapeutics Secures Worldwide Development and Commercia |
Coeptis Therapeutics Returns Distribution Density
The distribution of Coeptis Therapeutics' historical returns is an attempt to chart the uncertainty of Coeptis Therapeutics' future price movements. The chart of the probability distribution of Coeptis Therapeutics daily returns describes the distribution of returns around its average expected value. We use Coeptis Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Coeptis Therapeutics returns is essential to provide solid investment advice for Coeptis Therapeutics.
| Mean Return | 2.09 | Value At Risk | -15.97 | Potential Upside | 22.28 | Standard Deviation | 14.15 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Coeptis Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Coeptis Stock Institutional Investors
The Coeptis Therapeutics' institutional investors refer to entities that pool money to purchase Coeptis Therapeutics' securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Commonwealth Equity Services Inc | 2024-09-30 | 0.0 | Citadel Advisors Llc | 2024-12-31 | 0.0 | Arista Wealth Management Llc | 2024-12-31 | 0.0 | Vanguard Group Inc | 2024-12-31 | 0.0 | Geode Capital Management, Llc | 2024-12-31 | 0.0 | Meteora Capital, Llc | 2024-12-31 | 0.0 | Virtu Financial Llc | 2024-09-30 | 0.0 | Advisor Group Holdings, Inc. | 2024-09-30 | 0.0 | Cambridge Invest Research Advisors, Inc. | 2024-12-31 | 0.0 | Ubs Group Ag | 2024-12-31 | 6.8 K | Mint Tower Capital Management B.v. | 2024-12-31 | 2.2 K |
Coeptis Therapeutics Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 505.0 | (237.1K) | 2.0M | 1.6M | (2.3M) | (2.2M) | |
| Net Income | (2.2K) | (9.2M) | (13.4M) | (37.6M) | (21.3M) | (20.2M) | |
| Depreciation | 35.0K | 323.4K | 447.4K | 1.0M | 1.0M | 599.1K |
Coeptis Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Coeptis Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Coeptis Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Coeptis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 2.05 | |
β | Beta against Dow Jones | -0.17 | |
σ | Overall volatility | 14.58 | |
Ir | Information ratio | 0.16 |
Coeptis Therapeutics Volatility Alert
Coeptis Therapeutics is showing large volatility of returns over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Coeptis Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Coeptis Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Coeptis Therapeutics Fundamentals Vs Peers
Comparing Coeptis Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Coeptis Therapeutics' direct or indirect competition across all of the common fundamentals between Coeptis Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Coeptis Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Coeptis Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Coeptis Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Coeptis Therapeutics to competition |
| Fundamentals | Coeptis Therapeutics | Peer Average |
| Return On Equity | -14.81 | -0.31 |
| Return On Asset | -1.87 | -0.14 |
| Current Valuation | 36.3 M | 16.62 B |
| Shares Outstanding | 39.72 M | 571.82 M |
| Shares Owned By Insiders | 18.53 % | 10.09 % |
| Shares Owned By Institutions | 4.05 % | 39.21 % |
| Number Of Shares Shorted | 13.84 K | 4.71 M |
| Price To Book | 7.39 X | 9.51 X |
| Price To Sales | 45.68 X | 11.42 X |
| Gross Profit | 75 K | 27.38 B |
| EBITDA | (20.16 M) | 3.9 B |
| Net Income | (21.27 M) | 570.98 M |
| Cash And Equivalents | 2.38 M | 2.7 B |
| Cash Per Share | 0.06 X | 5.01 X |
| Total Debt | 1.22 M | 5.32 B |
| Debt To Equity | 1.89 % | 48.70 % |
| Current Ratio | 0.56 X | 2.16 X |
| Book Value Per Share | (0.01) X | 1.93 K |
| Cash Flow From Operations | (7.24 M) | 971.22 M |
| Short Ratio | 0.40 X | 4.00 X |
| Earnings Per Share | (0.47) X | 3.12 X |
| Target Price | 3.0 | |
| Number Of Employees | 5 | 18.84 K |
| Beta | -0.94 | -0.15 |
| Market Capitalization | 8.06 M | 19.03 B |
| Total Asset | 4.57 M | 29.47 B |
| Retained Earnings | (87.36 M) | 9.33 B |
| Working Capital | 2.26 M | 1.48 B |
| Net Asset | 4.57 M |
Note: Acquisition by Calise Chris of 5700 shares of Coeptis Therapeutics at 10.56 subject to Rule 16b-3 [view details]
Coeptis Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Coeptis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 907.04 | |||
| Daily Balance Of Power | 0.1915 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 11.12 | |||
| Day Typical Price | 11.11 | |||
| Price Action Indicator | 0.03 | |||
| Period Momentum Indicator | 0.09 |
About Coeptis Therapeutics Buy or Sell Advice
When is the right time to buy or sell Coeptis Therapeutics? Buying financial instruments such as Coeptis Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Coeptis Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Airlines Thematic Idea Now
Airlines
Domestic and international airlines and airline services. The Airlines theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Airlines Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Coeptis Stock Analysis
When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.